Alto Neuroscience ANRO Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Alto Neuroscience in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alto Neuroscience's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alto Neuroscience's accounts payable?
- Alto Neuroscience (ANRO) reported accounts payable of $3.37M in Q1 2026.
- How has Alto Neuroscience's accounts payable changed year-over-year?
- Alto Neuroscience's accounts payable increased by 143.4% year-over-year, from $1.38M to $3.37M.
- What is the long-term trend for Alto Neuroscience's accounts payable?
- Over 2 years (2023 to 2025), Alto Neuroscience's accounts payable has grown at a 139.1% compound annual growth rate (CAGR), from $1.22M to $6.99M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.